(YULC) Yule Catto
Summary
Buy UK shares for just £1.50. No hidden charges, admin or inactivity fees
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Headline | Source | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||||||||||
| 11-01-12 | RNS |
|||||||||||||||||
|
RNS Number : 3366V Yule Catto & Co PLC 11 January 2012
11 January 2012
Yule Catto & Co plc
Trading Update
Yule Catto & Co plc ("Yule Catto" or the "Group"), the international producer of speciality chemicals, today issues a trading update ahead of its preliminary results announcement for the year to 31 December 2011.
Profitability has remained very much in line with the Board's expectations at the time of the third quarter interim management statement.
Along with most of the chemical sector, the Group has seen further reductions in demand in the fourth quarter. Following the modest volume reductions reported for the third quarter, percentage volume declines in the fourth quarter have been in the mid teens. These volume declines have been largely offset by continued margin management.
Net debt has fallen substantially with lower working capital requirements and proceeds from the sale of the Pharma division. Year end net debt is expected to be comfortably below £200M.
Synergy delivery from the acquisition of PolymerLatex continues to progress well and to plan. The Group exited the year with an annualised run rate of £15m, and remains on track to deliver the planned annual synergies of at least £20m in the second 12 months post acquisition. The Board expects the impact of these synergies to add some £14M of profit in 2012 compared to 2011.
The Board expects full year underlying profit before tax to be in line with current market expectations.
The Group expects to announce its 2011 full year results on 14 March 2012.
- Ends -
Enquiries:
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||
| 09-01-12 | RNS |
|||||||||||||||||
|
RNS Number : 2100V Yule Catto & Co PLC 09 January 2012 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. 1. Name of the issuer
YULE CATTO & CO PLC
2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2R; (ii) a disclosure made in accordance with LR 9.8.6R(1); or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006)
(i)
3. Name of person discharging managerial responsibilities/director
DR ALEXANDER DOBBIE
4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person
NOTIFICATION RELATES TO DR A A DOBBIE AND HIS WIFE - MRS M S DOBBIE
5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest
NOTIICATION IS IN RESPECT OF THE BENEFICAL HOLDINGS OF DR DOBBIE AND HIS WIFE.
6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares
ORDINARY SHARES OF 10P EACH
7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them
TD DIRECT INVESTING NOMINEES (EUROPE) LIMITED
8. State the nature of the transaction
SALE AND PURCHASE OF SHARES
9. Number of shares, debentures or financial instruments relating to shares acquired
25,000 SHARES
10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
0.007%
11. Number of shares, debentures or financial instruments relating to shares disposed
25,000 SHARES
12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
0.007%
13. Price per share or value of transaction
25,000 SHARE TRANSFERRED BY DR A A DOBBIE TO MRS M S DOBBIE AT NIL CONSIDERATION
14. Date and place of transaction
3 JANUARY 2012
15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
TOTAL HOLDIG UNCHANGED AT 114,853 SHARES; 0.034% OF ISSUED SHARE CAPITAL
16. Date issuer informed of transaction
5 JANUARY 2012
If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes 17 Date of grant
18. Period during which or date on which it can be exercised
19. Total amount paid (if any) for grant of the option
20. Description of shares or debentures involved (class and number)
21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise
22. Total number of shares or debentures over which options held following notification
23. Any additional information
24. Name of contact and telephone number for queries
RICHARD ATKINSON TEL: 01279 459512
Name and signature of duly authorised officer of issuer responsible for making notification
RICHARD ATKINSON - COMPANY SECRETARY
Date of notification 9 JANUARY 2012
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||
| 03-01-12 | RNS |
|||||||||||||||||
|
RNS Number : 9322U Yule Catto & Co PLC 03 January 2012 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. 1. Name of the issuer
YULE CATTO & CO PLC
2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2R; (ii) a disclosure made in accordance with LR 9.8.6R(1); or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006)
(i)
3. Name of person discharging managerial responsibilities/director
DR ALEXANDER DOBBIE
4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person
NOTIFICATION RELATES TO DR A A DOBBIE AND HIS WIFE - MRS M S DOBBIE
5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest
NOTIICATION IS IN RESPECT OF THE BENEFICAL HOLDINGS OF DR DOBBIE AND HIS WIFE.
6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares
ORDINARY SHARES OF 10P EACH
7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them
TD DIRECT INVESTING NOMINEES (EUROPE) LIMITED
8. State the nature of the transaction
SALE AND PURCHASE OF SHARES
9. Number of shares, debentures or financial instruments relating to shares acquired
16,000 SHARES
10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
0.005%
11. Number of shares, debentures or financial instruments relating to shares disposed
16,000 SHARES
12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
0.005%
13. Price per share or value of transaction
16,000 SHARES SOLD BY DR A A DOBBIE AT £1.6414 PER SHARE 3,000 SHARES BOUGHT BY DR A A DOBBIE AT £1.6487 PER SHARE 13,000 SHARES BOUGHT BY MRS M S DOBBIE AT £1.6546 PER SHARE
14. Date and place of transaction
31 DECEMBER 2011
15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
TOTAL HOLDIG UNCHANGED AT 114,853 SHARES; 0.034% OF ISSUED SHARE CAPITAL
16. Date issuer informed of transaction
3 JANUARY 2012
If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes 17 Date of grant
18. Period during which or date on which it can be exercised
19. Total amount paid (if any) for grant of the option
20. Description of shares or debentures involved (class and number)
21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise
22. Total number of shares or debentures over which options held following notification
23. Any additional information
24. Name of contact and telephone number for queries
RICHARD ATKINSON TEL: 01279 459512
Name and signature of duly authorised officer of issuer responsible for making notification
RICHARD ATKINSON - COMPANY SECRETARY
Date of notification 3 JANUARY 2012
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||
| 01-12-11 | RNS |
|||||||||||||||||
|
RNS Number : 1072T Yule Catto & Co PLC 01 December 2011
1 December 2011
Yule Catto & Co plc
Disposal of Pharma Division
Yule Catto & Co plc ("Yule Catto" or the "Group"), the international producer of specialty chemicals, is pleased to announce the sale of its non-core Pharma Chemicals division, Uquifa, to Vivimed Labs, an emerging global player in pharma, with strong interests in Europe, for a total consideration of £35.0 million.
The proceeds comprise £28.6 million paid in cash and an unconditional payment of £6.4 million deferred for three years, covered by an irrevocable UK bank guarantee. The proceeds will be used to pay down Group indebtedness.
Uquifa is a manufacturer of Active Pharmaceutical Ingredients and intermediates for the pharmaceutical industry. It operates three manufacturing sites, two in Spain and one in Mexico, employing a total of 390 people. Mark Robbins, CEO of Uquifa, and a member of the Yule Catto executive management team, will transfer with the business.
The Pharma division reported an operating profit of £4.45 million in the year to 31 December 2010, and had net assets of £41.6 million (gross assets of £63.7 million), as at 30 June 2011. The transaction is expected to have a slightly dilutive effect on the Group's earnings.
Adrian Whitfield, Chief Executive of Yule Catto, commented:
"I am delighted to be able to announce this disposal. Following the PolymerLatex acquisition we completed earlier this year, this marks the final step in a long process of transforming Yule Catto into a substantial highly focussed Specialty Polymer business. We are pleased we have been able to find a good home for our Pharma business and wish the new owners and our former employees every success."
- Ends -
Enquiries: Yule Catto Adrian Whitfield, Chief Executive Tel: 01279 442791 David Blackwood, Group Finance Director
MHP Communications Andrew Jaques / John Olsen / Ian Payne Tel: 020 3128 8100
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||
| Result Pages: 1 | ||||
| Date/Time | Subject | Author | ||
|---|---|---|---|---|
| 13:28 |
1 |
|||
|
|
||||
|
|
||||
|
The Buzz
Haha, swine ! No, this price rise isn't down to me. I think we're just rising on the hope that, if the world looks like it's making an effort to sort it's problems out, then YULC should outperform. If the brokers forecasts are right then we're looking at below 1.0 PEG's for the next few years. In my head, my next set of profit taking is between 220 and 230p. Watch this space BB |
||||
| 13:14 | ||||
|
|
||||
|
|
||||
|
BB,
Have you sold some more shares in YULC? Price has been on a good run just recently and keeps on creeping up today. Now 208-208.5p. There was vague take-over talk re Dow chemicals circulating before. Then we had a bit of a Euro crash and the wind was taken out of the market. However since then things seem to have improved. The Euro crisis seems to have eased a bit now, a mega merger with Xstata rekindles take-over prospects and the Chinese economy continues to thrive (hence good for YULC in the Far East). Are more rumours on a Dow bid coming back I wonder? Crumbs - price now 208.6-208.9p now. Sorry now 209.3-209.5p. Looking good from here!! The Buzz |
||||
| 20-01-12 |
1 |
|||
|
|
||||
|
|
||||
|
|
||||
| 19-01-12 |
2 |
|||
|
|
||||
|
|
||||
|
MARKET REPORT: Bank bashing fund managers become buyers
By GEOFF FOSTER Last updated at 10:06 PM on 19th January 2012 http://bit.ly/wYb8x3 |
||||
|
|
||||
They have not been approved or issued by Interactive Investor Trading Limited.
Editor's Pick:
Markets: FTSE 100 in the black as Bank announces more QEEditor's Pick:
View from the top: Tangiers Petroleum interviewEditor's Pick:
Greece strikes bail-out agreementEditor's Pick:
Bank announces £50bn quantitative easing packageEditor's Pick:
Mixed outlook for trio of mining giantsEditor's Pick:
Glenstrata's just a silly word. Stick to big dividendsEditor's Pick:
Bulls should head for ChinaEditor's Pick:
George Godber’s AIM stock picks

